Qier Neng (奇尔能)奇尔能

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

药物知识说明

是氢溴酸加兰他敏是一种在国家药监局注册认定的药品。标注生产企业为丽珠集团丽珠制药厂。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂、丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂、丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 奇尔能) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 丽珠集团丽珠制药厂.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂, 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂, 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 奇尔能Recorded Chinese name: 奇尔能
  • 剂型Dosage form: 片剂Tablets

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 丽珠集团丽珠制药厂Chinese legal name: 丽珠集团丽珠制药厂

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20040590

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20040590

Manufacturer

Chinese legal name: 丽珠集团丽珠制药厂 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20040590

生产企业

丽珠集团丽珠制药厂(国产)

适应症

临床上主要用于治疗阿尔茨海默式病,对痴呆患者和脑器质性病变引起的记忆障碍亦有改善作用。

用法用量

饭后1小时口服。开始时一次5mg(一片),一日4次;三天后可改为一次10mg(二片), 一日4次或遵医嘱。

不良反应

1.个别病人开始服药时可能出现头晕、失眠、恶心、轻度腹痛及心率减慢。
2.还有个别患者会出现呼吸加快、血压变化、唾液增多,食欲低下,呕吐、腹部痉挛和疼痛、循环系统虚脱、肌肉痉挛、肌张力增高或麻痹,易激动、头痛、多尿、情绪沮丧等反应,继续用药后多能自行消失。

禁忌

1.对本品中任一成份过敏者禁用。
2.加兰他敏为胆碱酯酶抑制剂,在麻醉的情况下禁止使用。
3.心绞痛和心动过缓的患者禁用。
4.严重哮喘或肺功能障碍的病人禁用。
5.重度肝脏损害者禁用。
6.重度肾脏损害者禁用。
7.机械性肠梗阻的病人禁用。

注意事项

本品为胆碱酯酶抑制剂,其用量有个体差异,一般应从小剂量开始,按上述用法用量或遵医嘱,不良反应明显时可酌情减量。

贮藏

密封

证据Evidence

  • 批准文号: 国药准字H20040590
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.